Document is current

Article History

Received: 20 January 2025

Accepted: 22 May 2025

First Online: 31 May 2025

Declarations

:

: The local ethics committee of the University of Würzburg in Germany approved the study (ref. no. 62/23_awb-am). All patients gave written informed consent prior to study participation. The study was conducted in full accordance with the ethical principles outlined in the Declaration of Helsinki.

: Not applicable.

: JG, AA, FR, SH, BEW, CR and MS declare no conflicts of interest. PH received a research award from Vogel-Foundation and is a member of the Clinician Scientist Programme, Wuerzburg. PM received honoraria for scientific lectures from CSL Behring GmbH, Pharmacosmos GmbH, and CSL Vifor GmbH. PK received lecturing fees from TEVA, Sintetica, CSL Behring GmbH, Senzyme, Vifor Pharma GmbH, Pharmacosmos, and Grünenthal and consulted for TEVA, Milestone Scientific Inc, Sintetica and Amicus Ltd. CS received honoraria for scientific lectures and consulting fees from BBRAUN; Fresenius and Abiomed. All mentioned funders and especially the manufacturers of the investigated devices had no role in the design of the study; collection, analyses, or interpretation of data; writing of the manuscript; or in the decision to publish the results.